Using a validated tool, the study aimed to explore pharmacists' experiences of maintaining work/life balance in a large, nationally representative sample of pharmacists in Great Britain (GB).

A two-page postal questionnaire was sent in 2008 to all GB-domiciled pharmacists who were registered with the regulatory body for pharmacy in GB (just over 44 000 pharmacists). Demographic information, work patterns and other employment data were collected and analysed using regression techniques to explore the link between these characteristics and a validated measure of work/life balance.

The response rate to the census was 69.6% (n = 30 517). Eighty-three per cent (n = 25 243) of respondents were working as a pharmacist and were therefore eligible to complete the work/life balance statements. The results reported here relate to 12 364 individuals who had full data for the work/life balance scale and the demographic and work variables. Findings indicate that age, ethnicity, having caring responsibilities, sector of practice, hours of work and type of job are significant predictors of work/life balance problems.

Pharmacy employers and government should recognise the changing demographic characteristics of the profession and consider what support might be available to the workforce to help alleviate work/life balance problems being experienced by certain groups of pharmacists.

To describe the training undertaken by pharmacists employed in a pharmacist-led information technology-based intervention study to reduce medication errors in primary care (PINCER Trial), evaluate pharmacists' assessment of the training, and the time implications of undertaking the training.

Six pharmacists received training, which included training on root cause analysis and educational outreach, to enable them to deliver the PINCER Trial intervention. This was evaluated using self-report questionnaires at the end of each training session. The time taken to complete each session was recorded. Data from the evaluation forms were entered onto a Microsoft Excel spreadsheet, independently checked and the summary of results further verified. Frequencies were calculated for responses to the three-point Likert scale questions. Free-text comments from the evaluation forms and pharmacists' diaries were analysed thematically.

All six pharmacists received 22 h of training over five sessions. In four out of the five sessions, the pharmacists who completed an evaluation form (27 out of 30 were completed) stated they were satisfied or very satisfied with the various elements of the training package. Analysis of free-text comments and the pharmacists' diaries showed that the principles of root cause analysis and educational outreach were viewed as useful tools to help pharmacists conduct pharmaceutical interventions in both the study and other pharmacy roles that they undertook. The opportunity to undertake role play was a valuable part of the training received.

Findings presented in this paper suggest that providing the PINCER pharmacists with training in root cause analysis and educational outreach contributed to the successful delivery of PINCER interventions and could potentially be utilised by other pharmacists based in general practice to deliver pharmaceutical interventions to improve patient safety.

The aims of the study were to (i) quantify the sales of over-the-counter (OTC) ophthalmic chloramphenicol from all community pharmacies in Wales and investigate the impact on primary care prescriptions up to 5 years after reclassification and (ii) investigate the temporal relationship between items supplied OTC and on NHS primary care prescriptions.

Primary care prescription data (2004–2010) and OTC sales data (2005–2010) for ophthalmic chloramphenicol were obtained. The quantity sold OTC was calculated from pharmacy wholesale records and sales data from a large pharmacy multiple. Spearman's rank correlation for prescription and OTC supplies of ophthalmic chloramphenicol was calculated for data from January 2008 to December 2010.

OTC supply of chloramphenicol eye drops and ointment were both highest in 2007–2008 and represented 68% (57 708/84 304) and 48% (22 875/47 192) of the corresponding prescription volume, respectively. There was a steady year-on-year increase in the combined supply of OTC ophthalmic chloramphenicol and that dispensed on prescription from 144 367 items in 2004–2005 to 210 589 in 2007–2008 before stabilising in 2008–2009 and 2009–2010. A significant positive correlation was observed between prescription items and OTC sales of chloramphenicol eye drops and ointment combined (r = 0.7, P < 0.001).

OTC availability increased the total quantity of ophthalmic chloramphenicol supplied in primary care compared to that seen prior to reclassification. Although growth in the sales of ophthalmic chloramphenicol OTC has stabilised and the supply pattern mirrors primary care prescribers, further work is required to investigate whether use is appropriate and whether the publication of updated practice guidance has changed this.

Influenza vaccination rates achieved by general medical practice on the Isle of Wight, England, have been consistently lower than regional and national averages despite practices pursuing an active programme of patient engagement. The objective of this work was to determine whether inclusion of community pharmacies in an influenza vaccination programme improves vaccination rates and is acceptable to patients.

The Isle of Wight Primary Care Trust commissioned a community pharmacy seasonal influenza vaccination service to augment that offered by general medical practice. Vaccination rates were monitored as well as determining patient perception of a pharmacy-based service by self-administered survey.

Eighteen community pharmacies vaccinated 2837 patients and accounted for 9.7% of all patients vaccinated on the island. The pharmacy service contributed to improved patient vaccination rates in both the over- and under-65 age groups and increased the number of patients receiving a vaccination for the first time. Pharmacies vaccinated proportionately more carers and frontline healthcare workers than medical practices. Patient satisfaction with the pharmacy-based service was high, with access seen as a major advantage over general medical practice. The pharmacy-based service also vaccinated patients that ordinarily would not have accessed medical services.

Involvement of community pharmacies in the seasonal influenza vaccination programme can help increase vaccination rates and is associated with high levels of patient acceptability.

In aged-care facilities (ACFs) monitoring of warfarin can be logistically challenging and International Normalised Ratio (INR control) is often suboptimal. We aimed to determine whether an integrated information and communications technology system and the use of point-of-care (POC) monitors by nursing staff could improve the INR control of aged-care facility residents who take warfarin.

Nursing staff identified residents who were prescribed warfarin in participating ACFs. A computer program (MedePOC) was developed to store and transmit INR results from the ACFs to general practitioners (GPs) for dosage adjustment. Nursing staff received training in the use of the CoaguChek XS point-of-care INR monitor and the MedePOC software. Following a run-in phase, eligible patients were monitored weekly for up to 12 weeks. The primary outcome was the change in the time in therapeutic range (TTR) in the intervention phase compared to the TTR in the 12 months preceding the study. All GPs, nursing staff and patients were surveyed for their experiences and opinions of the project.

Twenty-four patients and 19 GPs completed the trial across six ACFs. The mean TTR for all patients improved non-significantly from 58.9 to 60.6% (P = 0.79) and the proportion of INR tests in range improved non-significantly from 57.1 to 64.1% (P = 0.21). The mean TTR improved in 14 patients (58%) and in these patients the mean absolute improvement in TTR was 23.1%. A post hoc analysis of the INR data using modified therapeutic INR ranges to reflect the dosage adjustment practices of GPs suggested that the intervention did lead to improved INR control. The MedePOC program and POC monitoring was well received by nursing staff.

Weekly POC INR monitoring conducted in ACFs and electronic communication of the results and warfarin doses resulted in non-significant improvements in INR control in a small cohort of elderly residents. Further research involving modification to the communication strategy and a longer follow-up period is warranted to investigate whether this strategy can improve INR control and clinical outcomes in this vulnerable population.

Medication errors can seriously affect patients and healthcare professionals. In over 60% of cases, medication errors are associated with one or more contributory; individual factors including staff being forgetful, stressed, tired or engaged in multiple tasks simultaneously, often alongside being distracted or interrupted. Routinised hospital practice can lead professionals to work in a state of mindlessness, where it is easy to be unaware of how both body and mind are functioning.

Mindfulness, defined as moment-to-moment awareness of the everyday experience, could represent a useful strategy to improve reflection in pharmacy practice. The importance of reflection to reduce diagnostic errors in medicine has been supported in the literature; however, in pharmaceutical care, reflection has also only been discussed to a limited extent. There is expanding evidence on the effectiveness of mindfulness in the treatment of many mental and physical health problems in the general population, as well as its role in enhancing decision making, empathy and reducing burnout or fatigue in medical staff.

Considering the benefits of mindfulness, the authors suggest that healthcare professionals should be encouraged to develop their practice of mindfulness. This would not only be beneficial in relieving stress, increasing attention levels and awareness, but it is believed that the integration of mindfulness and reflective practice in a ‘Mindful Reflective Practice’ could minimise some of the individual factors that lead to medication errors.

Mindfulness Reflective Practice could therefore represent an important element in pre-registration education and continual professional development for pharmacists and other healthcare professionals.

Personally Controlled Electronic Health Records (PCEHRs) were introduced for Australian health consumers in July 2012. This study aimed to determine, in the months prior to the launch, community pharmacists’ perceptions about practical and professional aspects relating to integration of the PCEHR into pharmacy practice, with a view to informing practice guidelines and training.

Semi-structured interviews with 25 pharmacy owners and/or managers from 24 community pharmacies in Perth, Western Australia, were undertaken during March–April 2012. Participants were given a standardised briefing about the PCEHR before exploratory questioning regarding the expected integration, benefits and challenges of the system in pharmacy practice.

Despite some awareness of the impending introduction of PCEHRs via the lay media, pharmacists were almost unanimously uninformed about the intended rollout, design and functionality of the system for health consumers and practitioners. Participants expressed concerns regarding patients’ control over their data management, time associated with staff training, technical upgrades and resource allocation. Obstacles included pharmacists’ inability to legitimately access patient data outside consultations. Pharmacists expected flexibility to record clinical activities and health services. Priorities identified for the profession were remuneration, medico-legal guidelines and boundaries, and clarification of roles and responsibilities.

Despite being unaware of details surrounding integration of PCEHRs in practice, community pharmacists provided insights into their expectations and concerns and the perceived benefits relating to implementation of the system. Training priorities and practice guidelines should address ethical data management and optimal use of electronic health records for clinical services.

To explore pharmacist–consumer interactions around the use of complementary medicines (CMs), with specific focus on consumer expectations, perceptions and satisfaction.

Twenty pharmacists and 20 healthcare consumers were recruited across 16 metropolitan community pharmacies in Adelaide, Australia, from June to August 2011. Semi-structured interviews containing comparable questions for both study groups were used. Data was transcribed and analysed with the aid of AutoMap®.

 There was high consumer satisfaction with pharmacists as CM providers, which was in agreement with pharmacist's perceptions of consumer satisfaction. However, this was against a background of low consumer expectations and pharmacists' dissatisfaction with their own role in the interaction. Consumers often perceived pharmacy-stocked CMs to be more effective and safer compared to those in supermarkets or health food shops, but this perception was not shared by pharmacists. Pharmacists believed they had significant influence around recommendation and use of CMs, whereas consumers perceived a more limited influence. Both pharmacists and consumers shared similar perceptions of CM safety and similar expectations regarding business influence and professional pressures on information provision.

Behind a perception of high satisfaction, consumers have low expectations of pharmacists around provision of CM-related information. Further work is required to improve pharmacists' knowledge and confidence around CM use and to address barriers such as the tension between potentially competing business pressures and professional responsibilities.

Multiple drug combination therapy aimed at controlling glucose, blood pressure, lipids and fibrinolysis significantly reduces micro- and macrovascular morbidity and mortality in patients with type 2 diabetes. The aims of this study were to (1) identify gaps between current medication management and evidence-based treatment targets in a rural cohort of Australian adults with type 2 diabetes and (2) determine patient factors associated with the prescribing of medications to patients with type 2 diabetes.

Two hundred and seventy-two medical records were randomly selected from a regional health service type 2 diabetes database. Demographic, biochemical, anthropometric, pharmacological, co-morbidity and lifestyle data during the initial 5 years post diagnosis were collected and analysed.

Five years post type 2 diabetes diagnosis only 12% of the cohort were meeting optimal targets for glucose, blood pressure, low-density lipoprotein, high-density lipoprotein and triglyceride. Younger age (odds ratio, OR 0.96; 95% confidence interval, CI 0.94–0.99; P < 0.05) and elevated urinary microalbumin (OR 1.02; 95% CI 1.01–1.03; P < 0.05) were significantly associated with anti-diabetic medication treatment. The only independent factor associated with pharmacological treatment for hypertension was elevated HbA1c (OR 1.4; 95% CI 1.0–2.0; P < 0.05). Patient factors associated with prescription of lipid-lowering agents were a past history of cardiovascular disease (OR 5.0; 95% CI 2.0–12.5; P < 0.001), concurrent use of anti-hypertensive agents (OR 2.6; 95% CI 1.2–5.8; P < 0.05) and elevated triglyceride (OR 1.9; 95% CI 1.2–3.1; P < 0.01).

Treatment targets were not being translated into clinical practice in this cohort of patients with type 2 diabetes. Patients with acceptable HbA1c levels, with no history of cardiovascular disease and those taking few medications were at risk of being overlooked for the pharmacotherapy they required.

To examine the perceptions of disease aetiology and the effect of own behaviour on health among poly-pharmacy patients with non-Western backgrounds in Denmark.

The study was based on 26 extended medication reviews with patients of non-Western backgrounds aged 50+ who use at least four prescription drugs regularly. The reviews were conducted by 12 pharmacists with the same mother-tongue background as the participants. The reviews included patient interviews on which the data in this article are based. In total, four open-ended questions from the patient interviews were analysed by the means of Giorgi's phenomenological method.

The analysis shows that stress was most commonly perceived as the cause of the participants' diseases for reasons that included (1) having left their country of origin and family, (2) worry over the political situation in their country of origin and (3) the problems involved in living as an immigrant in Denmark. Most of the participants perceived their own efforts as having little impact on their own health status, although some participants considered them as having considerable influence.

To a great extent, the explanations of the participants about possible disease aetiology are focused on stress, immigration and psychological well-being. Although many participants perceived that their own efforts did not have much impact on their health status, our study revealed a large diversity in the responses of non-Western immigrants, particularly regarding the importance of their own efforts on their health status.

To describe a quality improvement initiative to improve deep-vein thrombosis (DVT) prophylaxis rates among hospitalized medicine patients.

A standardized admission order-set with an embedded risk-assessment tool and DVT prophylaxis orders was developed.

An audit 2 months after the intervention showed the use of optimal DVT prophylaxis was 91%, an increase from 75%. Chart review 1 year after the implementation of the order-set revealed that the increase in DVT prophylaxis was sustained at 95%.

The use of formalized quality improvement methods to implement an intervention is effective in changing physician behaviour.

The purpose of this study was to identify differences in difficulty and discrimination among multiple-choice examination items with regard to format and content in pharmacy therapeutics and pathophysiology (TP) courses.

Items from a TP course sequence were categorized by format and content by a faculty committee using the Delphi technique. Difficulty was not normally distributed; therefore, a logit transformation was employed. Difficulty and discrimination were analysed using one-way analysis of variance, with post hoc Bonferroni correction for pairs, to detect differences.

A total of 516 items were included, with approximately 233 students answering each item. Case-based items were statistically more difficult than Standard (P = 0.0007) or Statement items (P = 0.001) and more discriminatory than Standard items (P = 0.015). Dosing items were more difficult (P = 0.013) and discriminating (P = 0.02) than therapeutics items.

Case-based items appear to have been more difficult than other items and may provide greater discrimination than Standard items.

The objective of this article is to explore how giving women access to evidence-based information in weight management through pharmacies, and by utilising the World Wide Web, is a much needed step towards dealing with the obesity crisis.

Women's needs should be considered when developing evidence-based information on weight. Excess weight places them at high risk of diabetes and cardiovascular disease, infertility and complications following pregnancy and giving birth. Women are also an important population group because they influence decision-making around meal choices for their families and are the biggest consumers of weight-loss products, many of which can be purchased in pharmacies. Pharmacies are readily accessible primary healthcare locations and given the pharmacist's expertise in being able to recognise underlying causes of obesity (e.g. medications, certain disease states), pharmacies are an ideal location to provide women with evidence-based information on all facets of weight management. Considering the exponential rise in the use of the World Wide Web, this information could be delivered as an online educational resource supported by other flexible formats.

The time has come for the development of an online, evidence-based educational resource on weight management, which is combined with other flexible formats and targeted at women in general and according to different phases of their lives (pregnancy, post-partum, menopause). By empowering women with this knowledge it will allow them and their families to take better control of their health and wellbeing, and it may just be the much needed answer to complement already existing resources to help curb the obesity epidemic.

To determine the impact of advice provided by UK Medicines Information (MI) services on patient care and outcomes.

Healthcare professionals who contacted MI centres with enquiries related to specific patients in 35 UK National Health Service hospitals completed questionnaires before and after receiving MI advice. A multidisciplinary expert panel rated the impact in a sample of enquiries. One investigator used the panel's ratings and principles to rate all enquiries.

Of 179 completed questionnaire pairs, 178 (99%) enquirers used the advice provided. Most (145, 81%) judged advice had a positive impact: 110 (61.5%) on patient care, 35 (19.6%) on patient outcome. Medicines Information pharmacists actively advised on issues not previously identified by enquirers in 35 cases (19.6%). The expert panel judged that in 19/20 (95%) cases, advice had a positive impact on patient care or outcome, mainly due to risk reduction. Agreement was high between expert panel and enquirers' ratings of impact: 12 (60%) full agreement; 16 (80%) agreement within one point. The investigator's impact rating of the full sample was positive for 162 (92%) enquiries: 82 (47%) on patient care and 80 (45%) on actual or expected patient outcome.

Enquirers and an independent expert panel both determined that MI services provided useful patient-specific advice that impacted positively on patients. Reduction of risk was central to this impact. MI pharmacists frequently identified and advised on issues that clinicians using the service had not recognised themselves, this generally had a positive impact on patients.

To determine the relative benefits of three different models of advanced pharmacy practice experience (APPE) in successfully integrating the delivery of direct patient care into students' final year community pharmacy clerkships.

All fourth-year pharmacy students at the University of British Columbia were divided into one of three study arms for their community APPE: a 2 × 4-week rotation in a traditional format, a 1 × 8-week rotation where their preceptors had experienced a 2-day education course and a 1 × 8-week rotation with both preceptor education plus a 5-day pre-APPE in-store orientation and peer debriefing.

All 123 students conducted patient consultations and documented their care. Students in the pre-APPE + preceptor education arm provided nearly double the number of direct patient consultations than did students in the preceptor-education-only arm or the traditional 2 × 4-week arm. Numbers of drug-related problems identified and interventions performed per patient consult did not differ across study arms.

Pre-APPE orientation activities provided an enhanced learning environment, promoted greater student engagement, provided care to more patients, increased preceptor preparedness and enhanced in-store patient-centred care practice. Certain of these learning activities can also form part of third- and fourth-year introductory pharmacy practice experiences to prepare students for their final-year APPE.

The aim of this study was to examine pharmacists' perceptions of their professional identity, both in terms of how they see themselves and how they think others view their profession.

A qualitative study was undertaken, using group and individual interviews with pharmacists employed in the community, hospital and primary care sectors of the profession in England. The data were recorded, transcribed verbatim and analysed using the framework method.

Forty-three pharmacists took part in interviews. A number of elements help determine the professional identities of pharmacists, including attributes (knowledge and skills), personal traits (aptitudes, demeanour) and orientations (preferences) relating to pharmacists' work. The study identified the presence of nine identities for pharmacists: the scientist, the medicines adviser, the clinical practitioner, the social carer, the medicines maker, the medicines supplier, the manager, the business person and the unremarkable character. While the scientist was the strongest professional identity to emerge it nevertheless seemed to overlap and compete with other professional identities, such as that of the medicines maker.

The relatively high number of identities may reflect some degree of role ambiguity and lack of clear direction and ownership of what makes pharmacists unique, but also suggests a flexible view of their role.

The objective of this research was to explore pharmacists' knowledge of, experiences with and perception of factors interfering with their ability to provide non-prescription emergency contraceptive pill consultations in the Canadian province of Nova Scotia.

A self-administered paper questionnaire was mailed, using Dillman's tailored design method, to all pharmacists (n = 1123) registered with the Nova Scotia College of Pharmacists.

The response rate was 53.0% (595/1123), with 451 respondents working in community practice. Most respondents reported that they had provided consultations for the emergency contraceptive product Plan B since it became available without a prescription (93.6%), and that Plan B is kept behind the pharmacy counter (83.6%). Pharmacists most frequently (47.8%) reported spending 6–10 min providing Plan B consultations. Respondents were generally knowledgeable about Plan B; however, only 39.2% knew that it can be effective for up to 5 days and 69.3% knew that the incidence of vomiting is less than 50%. The factors interfering the most with providing Plan B consultations were lack of privacy (46.1%) and lack of staff to cover during the consultation (50.9%).

In general, Nova Scotia pharmacists are knowledgeable about emergency contraceptive pills; however, education regarding effective timing for use of such pills would be helpful. Private areas for counselling and consideration of pharmacy staffing schedules in community pharmacies may help address pharmacist concerns regarding their ability to provide Plan B consultations.

To explore pharmacists’ perceived needs on training required to undertake an expanded prescribing role taking account of their years of registration, current professional practice area and preferred prescribing model.

A piloted self-administered questionnaire was distributed nationally to a random sample of pharmacists. Data were analysed using SPSS version18 software where data cross-tabulations, chi-squared and one-way analyses of variance were performed.

A response rate of 40.4% (1049/2592) was achieved. Pathophysiology of conditions, principles of diagnosis, and patient assessment and monitoring were the most preferred training topics. There was no difference (P = 0.620) in pharmacists’ perceived needs for additional training with respect to the model of prescribing (i.e. supplementary or independent or both) and years of registration as pharmacists (P = 0.284). However, consultant pharmacists were less supportive of the need for additional training (P = 0.013). Pharmacists’ years of registration and professional practice influenced their training topic preferences. Supporters of an independent prescribing model only demonstrated a weaker preference for training in key therapeutic topics (P = 0.001).

This study provides information on key areas for consideration when training pharmacists for an expanded prescribing role. Although most pharmacists preferred a supplementary model of prescribing where doctors retain their diagnostic role, their strongest training preferences were for topics that provided pharmacists with further skills in patient diagnosis, assessment and monitoring.

The purpose of this study was to identify the type and frequency of drug-related problems (DRPs) that are encountered when dispensing secondary care prescriptions in community pharmacy.

A cross-sectional study was conducted attempting to recruit all patients presenting with secondary care prescriptions to a single community pharmacy in New Zealand over a 3-month period. The DRPs were recorded to allow analysis of the types and frequencies of the problems seen.

During the 3-month period 401 patients consented to participate and 840 prescription items were analysed. DRPs were identified in 20% of prescription items analysed (n = 172), affecting 38% patients (n = 155). Bureaucratic interventions concerning product availability and payment issues accounted for 55% and affected 11% of the prescription items analysed. The remaining 45% of DRPs concerned clinical and patient issues and affected 9% of prescription items.

This study has shown that the secondary–primary interface is problematic with respect to DRPs. Although pharmacists are in a position to identify and act on these DRPs, access to basic patient notes such as a discharge summary and including pharmacists in the communication between secondary and primary providers should assist in achieving seamless care for the patient and help to identify and prevent DRPs.

This is the first of two papers which explore the use of mixed-methods research in pharmacy practice. In an era of evidence-based medicine and policy, high-quality research evidence is essential for the development of effective pharmacist-led services. Over the past decade, the use of mixed-methods research has become increasingly common in healthcare, although to date its use has been relatively limited in pharmacy practice research. In this article, the basic concepts of mixed-methods research including its definition, typologies and advantages in relation to pharmacy practice research are discussed. Mixed-methods research brings together qualitative and quantitative methodologies within a single study to answer or understand a research problem. There are a number of mixed-methods designs available, but the selection of an appropriate design must always be dictated by the research question. Importantly, mixed-methods research should not be seen as a ‘tool’ to collect qualitative and quantitative data, rather there should be some degree of ‘integration’ between the two data sets. If conducted appropriately, mixed-methods research has the potential to generate quality research evidence by combining strengths and overcoming the respective limitations of qualitative and quantitative methodologies.

This study aimed to identify issues in diabetes self-management in an Australian Maltese community with type 2 diabetes mellitus, and to identify opportunities for community pharmacies to offer self-management support to these populations.

Individual, semi-structured interviews were conducted. A maximum variation sample was recruited from La Vallette Social Centre, Sydney, and interviewed by the investigator. Interviews were audio recorded, transcribed verbatim, and iteratively coded into themes by constant comparison using computer software. Cultural predictors of adherence were analysed.

Twenty-four participants were interviewed. Themes included diabetes knowledge, self-management behaviours, cultural predictors of adherence and interest in community pharmacy disease management services. Diabetes knowledge was generally limited. Although most participants practised some self-monitoring of blood glucose they lacked knowledge of practice recommendations. Participants generally undertook regular physical activity, though adherence to diet varied according to social influences. Cultural influences on perceptions included attitudes to practitioners, treatment and peer experiences. Enablers included attitudes towards financial independence and social integration while nurturers included family and community support. Participants expressed interest in accessing more support from their community pharmacy due to ease of access and interest in learning more about diabetes.

Patients from different backgrounds experience unique barriers to care, including poor written literacy and limited access to diabetes education, many of which are unrecognised by patients or practitioners. Pharmacists should become more proactive in offering culturally appropriate diabetes self-management support to these populations. Research into pharmacist perspectives of patient issues could identify training needs and guide strategies to improve their cultural competence.

To explore pharmacy stakeholders’ views on developing a postgraduate course to prepare hospital pharmacists for collaborative prescribing in Australia.

Semi-structured interviews were conducted with pharmacy stakeholders from universities, hospitals and professional organisations (n = 25) to gather views on the content, structure and delivery methods of a possible postgraduate prescribing course for pharmacists. Transcripts were analysed thematically and coded using NVivo software.

There was strong support for collaborative prescribing as an appropriate role for advanced pharmacist practitioners and acknowledgement that further training is needed to implement this new role. It was proposed that postgraduate training for hospital pharmacists should be based on a national prescribing competency framework and participants highlighted key aspects of the prescribing process in which pharmacists need particular up-skilling: diagnosis, physical assessments, clinical decision-making and consultations. The training model used in the UK was favoured, where candidates undertake university-based study combined with collaborative training with a doctor and a practical assessment of competency.

The findings from this study have provided valuable information which can provide a pathway for the development of a postgraduate course to prepare Australian hospital pharmacists for prescribing. Future research should focus on uncovering the perceptions of Australian doctors, nurses and policy makers on the training requirements needed for pharmacist prescribing in the hospital setting. Stakeholders’ views on pharmacist prescribing training in the community setting could also be explored.

Clinical pharmacy services are still in the early stages of implementation in the Middle East. This study assessed the implementation of clinical pharmacy services at a major university hospital.

All recommendations and services provided by clinical pharmacists were recorded for a period of 7 months.

During the study period a total of 3026 patients were followed up and 10 783 recommendations and services were provided. The physicians' rate of acceptance of clinical pharmacists' recommendations was 69.4%.

The implementation of clinical pharmacy services in this setting was successful and should positively impact patient care.

To understand members of the public's opinions and experiences of pharmacy services.

This exploratory study employed qualitative methods. Five focus groups were conducted with 26 members of the public resident in Scotland in March 2010. The groups comprised those perceived to be users and non-users of community pharmacy. A topic guide was developed to prompt discussion. Each focus group was recorded, transcribed, anonymised and analysed using thematic analysis.

Participants made positive comments about pharmacy services although many preferred to see a general practitioner (GP). Participants discussed using pharmacies for convenience, often because they were unable to access GPs. Pharmacists were perceived principally to be suppliers of medicine, although there was some recognition of roles in dealing with minor ailments and providing advice. For those with serious and long-standing health matters GPs were usually the professional of choice for most health needs. Community pharmacy was seen to offer incomplete services which did not co-ordinate well with other primary-care services. The pharmacy environment and retail setting were not considered to be ideal for private healthcare consultations.

This study suggests that despite recent initiatives to extend the role of community pharmacists many members of the general public continue to prefer a GP-led service. Importantly GPs inspire public confidence as well as offering comprehensive services and private consultation facilities. Improved communication and information sharing between community pharmacists and general practice could support community pharmacist-role expansion.

This hypothesis-generating study examined the clinical, humanistic and economic impact of providing differentiated medication information depending on the patient's information desire as compared with undifferentiated information to patients with a major depressive episode at hospital discharge.

A longitudinal multi-centre study with quasi-experimental design comprised two experimental groups ((un)differentiated antidepressant information) and one ‘no information’ group. Patients were followed up for 1 year assessing adherence, economic outcomes (i.e. costs of medicines, consultations, productivity loss and re-admissions), clinical outcomes (i.e. depressive, anxiety and somatic symptoms and side effects) and humanistic outcomes (i.e. quality of life, satisfaction with information). A linear model for repeated measures was applied to assess differences over time and between groups.

Ninety-nine patients participated. Still participating 1 year later were 78. No beneficial effect was observed for adherence. Lower productivity loss (P = 0.021) and costs of consultations with healthcare professionals (P = 0.036) were observed in the differentiated group. About one-third of patients were re-admitted within 1 year following discharge. Patients in the ‘no information’ group had significantly more re-admissions than patients in the undifferentiated group (P = 0.031).

The hypothesis of differentiated information could be supported for economic outcomes only. Future medication therapy intervention studies should apply a more rigorous study design.

To determine the common stages and strategies involved in the dispensing accuracy-checking process used by pharmacy staff and to determine the training activities used by these staff to gain the knowledge and skills for accuracy checking.

Face-to-face tape-recorded ethnographic interviews (n = 28) were undertaken in 2009–2010 at two large teaching hospitals with a purposive sample of pharmacists and accredited checking technicians qualified to undertake the final accuracy check on dispensed medicines. Participants described their accuracy-checking process, strategies used to aid checking using anonymised prescriptions and accurate dispensing of medicines to aid discussion. The range of training activities undertaken to develop this skill were discussed. Qualitative data were analysed in accordance with the principles of grounded theory to identify themes.

The accuracy-checking process was described as a cognitive and systematic process. The order in which accuracy checking was executed was found to follow two pathways, with all participants checking the prescription first before verifying either the label or dispensed product. Various physical and sensory aids were used to assist in this verification process. There were inconsistencies in the level of accuracy-checking training received by pharmacists and accredited checking technicians, with many pharmacists reporting no training.

Although an important medication-error prevention strategy, until this study little was known about the process used by pharmacy staff when verifying the accuracy of dispensed medicines. Accuracy checking is a complex cognitive task involving verification of the product and label with the prescription. Strategies obtained during past experience and in training were used to aid checking. The study highlighted that pharmacy staff training to undertake this task was variable. Application of strategies identified in this study may allow individuals to adopt further safeguards to improve patient safety.

To explore participants' opinions and preferences on tailored written medicines information.

Forty-five participants were recruited to eight focus groups, run concurrently in Australia (23 participants in four groups) and the UK (22 participants in four groups). Participants were provided with exemplar leaflets for a cardiovascular medicine based on the angiotensin-converting enzyme (ACE) inhibitor ramipril, which was tailored for a man aged 55 with hypertension. Reference to other indications of the medicine, children's doses, pregnancy and breast-feeding information were removed. A topic guide directed the discussion and explored preferences and opinions on tailored leaflets. Focus group discussions were recorded, transcribed verbatim and content analysed using adapted cross-case study analysis.

Participants welcomed the concept of tailored information, desiring shorter and more relevant information. Information tailored to their condition or disease was most sought-after, followed by tailoring by age or gender. However, some participants voiced concerns about the potential for the wrong information being given to patients who would be unable to recognise that it was incorrect. Other concerns included how tailoring might impact upon the quality of information available and the feasibility of delivery, especially regarding the legal implications (Australia) and the cost (UK). A key finding was the participants' desire for a truly individualised approach to tailoring medicines information, as opposed to the generalised tailored information provided in the study. Participants said they would value having spoken communication with a healthcare professional at the same time as they received tailored leaflets.

Most participants welcomed tailored leaflets but overall valued a more personalised approach than the generalised tailored information we provided. Despite concerns about quality and delivery, many felt tailoring written medicines information could improve the relevance of the information to the individual and potentially encourage them to value it.

The aim of this review was to establish type(s) and possible cause(s) of medicine-related problems (MRPs) experienced by ethnic minorities in the UK and to identify recommendations to support these patients in the effective use of medicines.

A systematic search of studies related to problems with medicine use experienced by ethnic minorities in the UK was performed using the following databases: PubMed, Embase, International Pharmaceutical Abstract and Scopus from 1990 to 2011. A hand search for relevant citations and key journals was also performed.

Fifteen studies were found. The MRPs identified across studies included lack of information, problems with not taking medicines as advised, concern of dependency or side effects, lack of regular monitoring and review, risk of adverse drug reactions, adverse events and problems in accessing healthcare services. Many problems are common in other groups, however, studies examining possible explanatory factors discussed how the cultural and religious beliefs, previous experiences, different expectations, language and communication barriers, lack of knowledge of the healthcare services and underestimating patients' desire for information may contribute to the problems. Some of the recommendations were made based on the problems that were found, but these have not been evaluated.

Little evidence is known of what influences MRPs among ethnic minorities, despite the increased diversification of populations in countries throughout the world. To support their entire populations in the use of medicines, we have to ensure that we understand their different perspectives and needs regarding the effective use of medicines.

The study evaluated the interpretation of, and preferences for, numerical information on side-effect incidence when presented in three different formats.

It used a controlled design, with participants allocated at random to receive one of the three formats. Participants were recruited via a pop-up window on the CancerHelp UK website. The sample comprised 129 website users, of whom 96% were women and 86% had cancer, who received frequency information on four side effects of tamoxifen, using one of three risk expressions (percentages, e.g. ‘affects 25% of people’; frequencies, e.g. ‘affects 1 in 4 people’; combined, e.g. ‘affects 1 in 4 people (25%)’). They then interpreted information on tamoxifen and its effect on health, and estimates of side-effect frequency, and then stated a preference from the three risk expression formats.

The results showed that the three formats did not influence participants’ ratings of the information or their side-effect estimates. However, more than half (53%) the participants preferred the combined (frequency and percentage) format. In conclusion, a combined risk expression format performed no worse than percentages or frequencies alone and was preferred by a majority.

The three risk expression formats did not differ in their effect on participants’ interpretations. However, the preferred format was the combined (frequency and percentage) risk expression.

To explore consumers' beliefs and preferences for benefit information in medicine leaflets and examine their understanding and reaction to treatment benefits.

Forty-five participants were recruited to eight focus groups, run concurrently in Australia (23 participants in four groups) and the UK (22 participants in four groups). Participants were provided with amended leaflets based on the medicine clopidogrel, containing textual and numerical benefit information presented using numbers needed to treat (NNT). A topic guide which explored use of leaflets, preferences and opinions was used to direct discussion. Focus group discussions were recorded, transcribed verbatim and content analysed using adapted cross-case study analysis.

The consensus was that the inclusion of benefit information was a positive factor. Many participants felt that textual benefit information offered an incentive to take a medicine, although some Australian participants had concerns that included benefit information could create anxiety. The presentation of numerical benefit information provoked strong feelings of disbelief and shock. Participants were surprised that so few people would benefit. Some participants struggled to understand and interpret the NNT and others found it difficult to comprehend the magnitude of the benefit information, instead operating on initial and often crude assumptions of what the data meant. In both countries the provision of numerical benefit information appeared to shake participants' faith in drug treatments. Participants were concerned about how this might affect the ‘less-informed’ patient. However, in the UK, participants stated that their adherence to treatment was also reinforced by their doctor's advice.

Participants wanted to receive information about the benefits of their medicines. However, they may misinterpret the numerical information provided.

Compared to the general population, chronic kidney disease patients are more vulnerable to gastrointestinal haemorrhage and its morbidity and mortality. Due to the fear of gastrointestinal bleeding consequences in these patients on the one hand, and the perception of general safety of acid suppressive medications on the other hand, inappropriate stress ulcer prophylaxis (SUP) seems to be encountered in nephrology wards. The objectives of this study were to evaluate appropriateness of acid suppression therapy in kidney disease patients and to assess the role of clinical pharmacists to decrease inappropriate SUP prescribing and related costs for these patients.

All inpatients at nephrology wards of a teaching hospital were assessed regarding appropriate SUP prescribing during a 6-month pre-intervention phase of the study without any clinical pharmacists' involvement in patients' management. Thereafter, during a 6-month post-intervention phase clinical pharmacists provided local SUP protocol and educational classes for physicians regarding appropriate SUP prescribing and participated actively in the patient-care team.

The results showed significant relative reduction in inappropriate SUP prescribing and related cost in patients with renal insufficiency by about 44% and 67% respectively.

This study showed that implementing institutional guidelines, and active involvement of clinical pharmacists in the nephrology healthcare team, could reduce inappropriate SUP prescribing and related costs for these patients.

The aim of the study was to explore the range of dermatology medicines use reviews (MURs) undertaken by pharmacists and their confidence in dealing with the provision of advice to patients with skin problems.

A self-completion questionnaire was sent to a random sample of 3500 community pharmacies in England and Wales, UK.

A total of 870 pharmacists responded to the survey giving a response rate of 25% (870/3500). Nearly half of respondents (44%, n = 866) had undertaken a dermatology MUR with eczema/dermatitis and psoriasis being the main conditions encountered. The mean confidence score (on a five-point scale) at conducting dermatology MURs was 3.5 (SD 1.0).

Many pharmacists currently undertake dermatology MURs and rate themselves as confident in this role. Further work is needed to establish if such reviews lead to improvements in disease specific outcomes.

Appropriate household storage and use of drug products can reduce drug wastage and unnecessary hazards. We aimed to quantify the amounts and types of medications that were stored in Jordanian households and the extent of drug wastage in terms of the amount and cost of these medications.

The setting was households in Amman, Jordan. This was a cross-sectional survey study using a pre-piloted questionnaire. Family members were interviewed in person about use of drug products, and where drug products were stored. The main outcomes were types, storage methods, cost and quantities of drug products in every household.

Two hundred and forty-three households were approached, out of which 219 agreed to participate. A total of 2393 (mean 10.9, SD 5.2) drug products were recorded from the 219 households surveyed. A significant positive correlation was noted between the number of drug products in a household and family size (r = 0.19, P < 0.01), the level of the mother's education (r = 0.24, P < 0.01), the level of the father's education (r = 0.28, P < 0.01) and income (r = 0.14, P = 0.034). Eighty nine (40.6%) households had at least one child younger than 6 years of age, and 1122 (46.9%) drug products were stored in unsafe places in the houses, within the reach of children. More than a quarter of drug products (1509, 27.2%) were not in their original containers, 360 (15%) were unused since dispensing, 261 (10.9%) had expired and 44 (1.8%) had no clear expiry date. We estimated that the cost of drug wastage in the 219 households was US$5414. Paracetamol (202, 8.4%), diclofenac (98, 4.1%) and amoxicillin (79, 3.3%) were the most commonly reportedly stored individual drugs.

Drug products are stored in large quantities in Jordanian households. Unsafe storage practices have the potential to pose safety hazards, especially to children.

To design and test the feasibility of two questionnaires in German community pharmacies exploring self-reported adherence to antihypertensives.

Two self-report questionnaires were designed for patients treated with antihypertensives. The 29-item-questionnaire (long form, LF) was completed by pharmacists interviewing patients who were on the premises filling a prescription. The short form (SF; 19 items) was sent by pharmacies to patients via mail. The acceptance of the instruments by patients and pharmacists as well as the feasibility to measure medication-taking behaviour was investigated. Adherence was investigated by using a modified 5-(LF) or 6-item (SF) Morisky score.

Of 44 community pharmacies contacted, 18 agreed to participate. Patients' response rates were 428/915 (46.8%) for the SF and 249/760 (32.8%) for the LF. One hundred and seventy-nine patients (41.8%) and 70 patients (28.1%) reported adherence problems according to the SF and LF respectively.

To our knowledge, this is the first attempt to develop a self-report instrument for the detection of non-adherence in patients taking antihypertensives in this setting in Germany. Patients were willing to provide detailed information about their medication-taking behaviour. Underestimation of non-adherence may be more pronounced when applying the questionnaire in the pharmacy.

This study aimed to gain a better understanding on perspectives of over-the-counter (OTC) codeine users and issues relating to codeine dependence in the community pharmacy setting. Examining OTC codeine users' experiences aimed to promote better understanding of OTC codeine dependence, and inform pharmacy practices.

Utilising a qualitative research methodology we conducted interviews with 20 participants who were OTC codeine users and met DSM IV criteria for codeine dependence.

Key themes identified included experience of participants acquiring OTC codeine and participants' interactions with pharmacists. The OTC codeine-dependent participants found it generally easy to access OTC codeine, describing ‘standard’ questioning, minimal intervention from pharmacists and only occasional refusal to supply. A better appearance and presentation was generally linked to easy codeine supply.

The experiences of participants suggest a number of barriers exist to effective intervention for OTC codeine dependence in the community pharmacy setting. Identification of these barriers will provide an opportunity to more effectively target interventions to reduce harm related to OTC codeine products. Increased involvement of pharmacists in OTC codeine sales was associated with help-seeking by codeine users.

The aim was to explore and describe community pharmacists' current and potential place in the cancer pain pathway. Objectives were to describe pharmacists' role in advising patients and their carers on optimum use of opioid drugs for pain relief, identify elements of medicines management that could be modified and identify opportunities for improved communication with patients and other professionals.

Semi-structured interviews were conducted with 25 community pharmacists in three areas of England. Data were analysed using the Framework method.

Pharmacists had no reliable method to identify patients with cancer and no access to disease stage and treatment plan information. There was little evidence of any routine communication with other professionals about patient care. Contact with patients was limited. Access to palliative care medicines could be problematic for patients and medicines use reviews (MURs) were rarely done. Interview data suggested variable levels of knowledge about optimal opioid use in cancer pain or awareness of patients' priorities. For some pharmacists, proactive involvement appeared to be inhibited by fear of discussing emotional and wider social aspects and accounts showed that a wide range of issues and concerns were raised by family members, indicating considerable unmet need. Pharmacists tended to assume information had already been provided by others and felt isolated from other care team members. Many felt that their potential contribution to cancer pain management was constrained but aspired to do more.

There is significant scope for improving access to and interaction with, community pharmacists by people with cancer pain and their families. Finding ways to embed pharmacists within palliative care teams could provide a starting point for a greater contribution to cancer pain management.

To evaluate the perceptions, expectations and experiences of physicians with regard to hospital-based pharmacists in the West Bank, Palestine.

A self-administered questionnaire was distributed to 250 physicians practising in four general hospitals in the West Bank, Palestine. The main sections of the questionnaire comprised a series of statements pertaining to physicians' perceptions, expectations and experiences with pharmacists.

One hundred and fifty seven questionnaires were completed and returned (response rate, 62.8%). The majority of respondents were most comfortable with pharmacists detecting and preventing prescription errors (76.4%; 95% confidence interval (CI) 69.5–81.2%) and patient education (57.9%; CI 51.2–63.4%) but they were not comfortable with pharmacists suggesting the use of prescription medications to patients (56.7%; CI 49.8–62.4%). Most physicians (62.4%; CI 56.8–69.1%) expected the pharmacist to educate their patients about the safe and appropriate use of their medication. However, approximately one-third (31.7%; CI 26.0–39.6%) did not expect pharmacists to be available for consultation during rounds. Physicians' experiences with pharmacists were less favourable; whereas 77% (CI 70.2–81.5%) of the physicians agreed that pharmacists were always a reliable source of information, only 11.5% (CI 6.2–16.4%) agreed that pharmacists appeared to be willing to take responsibility for solving any drug-related problems.

The present study showed that hospital physicians are more likely to accept traditional pharmacy services than newer clinical services for hospital-based pharmacists in the West Bank, Palestine. Pharmacists should therefore interact more positively and more frequently with physicians. This will close the gap between the physicians' commonly held perceptions of what they expect pharmacists to do and what pharmacists can actually do, and gain support for an extended role of hospital-based pharmacists in future patient therapy management.

To explore the challenges that Danish community pharmacy staff encounter when serving non-Western immigrant customers. Special attention was paid to similarities and differences between the perceptions of pharmacists and pharmacy assistants.

A questionnaire was distributed to one pharmacist and one pharmacy assistant employed at each of the 55 community pharmacies located in the five local councils in Denmark with the highest number of immigrant inhabitants.

The total response rate was 76% (84/110). Most respondents found that the needs of immigrant customers were not sufficiently assessed at the counter (n = 55, 65%), and that their latest encounter with an immigrant customer was less satisfactory than a similar encounter with an ethnic Danish customer (n = 48, 57%) (significantly more pharmacists than assistants: odds ratio, OR, 3.19; 95% confidence interval, CI, 1.27–8.04). Forty-two per cent (n = 35) perceived that immigrant customers put pressure on pharmacy staff resources, while 27% (n = 23) found that the immigrant customer group make work more interesting. More pharmacists than assistants agreed on the latter (OR, 3.43; 95% CI, 1.04–11.33). Within the past 14 days, 86% (n = 72) experienced that their advice and counselling were not understood by immigrant customers, whereas 49% (n = 41) experienced lack of understanding by ethnic Danes; and 30% (n = 25) had consciously refrained from counselling an immigrant, whereas 19% (n = 16) had done so with an ethnic Dane. Use of under-aged children as interpreters during the past month was reported by 79% of respondents. Regarding suggestions on how to improve encounters with immigrant customers, most respondents listed interventions aimed at patients, general practitioners and pharmaceutical companies.

Community pharmacy staff report poorer quality in their encounters with immigrant customers, including sub-optimal counselling and frequent use of under-aged children as interpreters. Our study also reveals certain differences across personnel groups, which may be explained by differences in level of education.

To investigate pharmacy students’ perceptions of research in general and attitudes towards pharmacy practice research (PPR) at each stage of the undergraduate programme and determine any relationship between perceptions and attitudes, and to validate a measure of attitudes towards PPR in an Australian cohort of pharmacy students.

A 23-item survey was administered to all students enrolled in each year of the 4-year pharmacy undergraduate programme, University of Sydney, Australia. Perceptions of research in general were measured with four items on a five-point semantic-differential scale and attitudes towards PPR with19 items on a five-point Likert scale.

In total 853 students responded to the survey (83% response rate). While students perceived research to be necessary, they found it difficult and were divided in their interests in pursuing research. Attitudes towards PPR were assessed within five identified domains: ‘role of PPR in the curriculum’, ‘engaging in PPR activities’, ‘confidence to do PPR’, ‘faculty involvement of students in PPR’ and ‘role of PPR in the profession’. Most participants agreed that PPR played an important part in the profession and curriculum but almost half of the cohort lacked confidence to undertake PPR, with very few holding positive attitudes towards all five domains. The PPR instrument was found to be valid and reliable. There were significant differences in perceptions and attitudes at various stages of the degree.

Future research should investigate changes in perceptions and attitudes in a single cohort over the 4-year degree, explore factors influencing attitudes and identify strategies for stimulating research interest.